In vitro, DR_MOMP predicted for DLD-1 and HCT-116 CRC cell lines similar responses to ABT-199 and FOLFOX despite differences in their BCL-2 and BCL-xL levels. Here, BCL2L1 is linked to colorectal carcinoma.